Selected research
Market Structure
Global Advanced Therapy Medicinal Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Advanced Therapy Medicinal Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Advanced Therapy Medicinal Products include Novartis, Vericel Corporation, UniQure, Spark Therapeutics, PHARMICELL, MEDIPOST, Kolon TissueGene, JCR Pharmaceuticals and Gilead Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Advanced Therapy Medicinal Products market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Advanced Therapy Medicinal Products and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Advanced Therapy Medicinal Products revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Advanced Therapy Medicinal Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Advanced Therapy Medicinal Products Segment by Company
Novartis
Vericel Corporation
UniQure
Spark Therapeutics
PHARMICELL
MEDIPOST
Kolon TissueGene
JCR Pharmaceuticals
Gilead Lifesciences
Celgene Corporation
Bluebird Bio
Advanced Therapy Medicinal Products Segment by Type
Tissue Engineered Product
Cell Therapy
Gene Therapy
CAR-T Therapy
Advanced Therapy Medicinal Products Segment by Application
Hospital
Clinic
Advanced Therapy Medicinal Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Therapy Medicinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Advanced Therapy Medicinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Therapy Medicinal Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Advanced Therapy Medicinal Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Advanced Therapy Medicinal Products industry.
Chapter 3: Detailed analysis of Advanced Therapy Medicinal Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Advanced Therapy Medicinal Productsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tissue Engineered Product
- Cell Therapy
- Gene Therapy
- CAR-T Therapy
Applications
- Hospital
- Clinic
Companies covered
- Novartis
- Vericel Corporation
- UniQure
- Spark Therapeutics
- PHARMICELL
- MEDIPOST
- Kolon TissueGene
- JCR Pharmaceuticals
- Gilead Lifesciences
- Celgene Corporation
- Bluebird Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Advanced Therapy Medicinal Products Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Tissue Engineered Product
- 1.2.3 Cell Therapy
- 1.2.4 Gene Therapy
- 1.2.5 CAR-T Therapy
- 1.3 Market Analysis by Application
- 1.3.1 Global Advanced Therapy Medicinal Products Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.4 Global Market Growth Prospects
- 1.5 Global Advanced Therapy Medicinal Products Growth Trends by Region
- 1.5.1 Global Advanced Therapy Medicinal Products Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Advanced Therapy Medicinal Products Market Size by Region (2021-2026)
- 1.5.3 Advanced Therapy Medicinal Products Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Advanced Therapy Medicinal Products Market Dynamics
- 2.1 Advanced Therapy Medicinal Products Industry Trends
- 2.2 Advanced Therapy Medicinal Products Industry Drivers
- 2.3 Advanced Therapy Medicinal Products Industry Opportunities and Challenges
- 2.4 Advanced Therapy Medicinal Products Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Advanced Therapy Medicinal Products Revenue by Company (2021-2026)
- 3.2 Global Advanced Therapy Medicinal Products Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Advanced Therapy Medicinal Products Key Company Head office and Area Served
- 3.4 Global Advanced Therapy Medicinal Products Company, Product Type & Application
- 3.5 Global Advanced Therapy Medicinal Products Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Advanced Therapy Medicinal Products Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Advanced Therapy Medicinal Products Players Market Share by Revenue in 2025
- 3.6.3 2025 Advanced Therapy Medicinal Products Tier 1, Tier 2, and Tier 3
4 Advanced Therapy Medicinal Products Market by Type
- 4.1 Global Advanced Therapy Medicinal Products Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Advanced Therapy Medicinal Products Market Size by Type (2021-2032)
- 4.3 Global Advanced Therapy Medicinal Products Market Size Share by Type (2021-2032)
5 Advanced Therapy Medicinal Products Market by Application
- 5.1 Global Advanced Therapy Medicinal Products Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Advanced Therapy Medicinal Products Market Size by Application (2021-2032)
- 5.3 Global Advanced Therapy Medicinal Products Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Novartis Advanced Therapy Medicinal Products Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Vericel Corporation
- 6.2.1 Vericel Corporation Company Information
- 6.2.2 Vericel Corporation Business Overview
- 6.2.3 Vericel Corporation Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Vericel Corporation Advanced Therapy Medicinal Products Product Portfolio
- 6.2.5 Vericel Corporation Recent Developments
- 6.3 UniQure
- 6.3.1 UniQure Company Information
- 6.3.2 UniQure Business Overview
- 6.3.3 UniQure Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 UniQure Advanced Therapy Medicinal Products Product Portfolio
- 6.3.5 UniQure Recent Developments
- 6.4 Spark Therapeutics
- 6.4.1 Spark Therapeutics Company Information
- 6.4.2 Spark Therapeutics Business Overview
- 6.4.3 Spark Therapeutics Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Spark Therapeutics Advanced Therapy Medicinal Products Product Portfolio
- 6.4.5 Spark Therapeutics Recent Developments
- 6.5 PHARMICELL
- 6.5.1 PHARMICELL Company Information
- 6.5.2 PHARMICELL Business Overview
- 6.5.3 PHARMICELL Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 PHARMICELL Advanced Therapy Medicinal Products Product Portfolio
- 6.5.5 PHARMICELL Recent Developments
- 6.6 MEDIPOST
- 6.6.1 MEDIPOST Company Information
- 6.6.2 MEDIPOST Business Overview
- 6.6.3 MEDIPOST Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 MEDIPOST Advanced Therapy Medicinal Products Product Portfolio
- 6.6.5 MEDIPOST Recent Developments
- 6.7 Kolon TissueGene
- 6.7.1 Kolon TissueGene Company Information
- 6.7.2 Kolon TissueGene Business Overview
- 6.7.3 Kolon TissueGene Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Kolon TissueGene Advanced Therapy Medicinal Products Product Portfolio
- 6.7.5 Kolon TissueGene Recent Developments
- 6.8 JCR Pharmaceuticals
- 6.8.1 JCR Pharmaceuticals Company Information
- 6.8.2 JCR Pharmaceuticals Business Overview
- 6.8.3 JCR Pharmaceuticals Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 JCR Pharmaceuticals Advanced Therapy Medicinal Products Product Portfolio
- 6.8.5 JCR Pharmaceuticals Recent Developments
- 6.9 Gilead Lifesciences
- 6.9.1 Gilead Lifesciences Company Information
- 6.9.2 Gilead Lifesciences Business Overview
- 6.9.3 Gilead Lifesciences Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Gilead Lifesciences Advanced Therapy Medicinal Products Product Portfolio
- 6.9.5 Gilead Lifesciences Recent Developments
- 6.10 Celgene Corporation
- 6.10.1 Celgene Corporation Company Information
- 6.10.2 Celgene Corporation Business Overview
- 6.10.3 Celgene Corporation Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Celgene Corporation Advanced Therapy Medicinal Products Product Portfolio
- 6.10.5 Celgene Corporation Recent Developments
- 6.11 Bluebird Bio
- 6.11.1 Bluebird Bio Company Information
- 6.11.2 Bluebird Bio Business Overview
- 6.11.3 Bluebird Bio Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Bluebird Bio Advanced Therapy Medicinal Products Product Portfolio
- 6.11.5 Bluebird Bio Recent Developments
7 North America
- 7.1 North America Advanced Therapy Medicinal Products Market Size (2021-2032)
- 7.2 North America Advanced Therapy Medicinal Products Market Size by Type
- 7.2.1 North America Advanced Therapy Medicinal Products Market Size by Type (2021-2026)
- 7.2.2 North America Advanced Therapy Medicinal Products Market Size by Type (2027-2032)
- 7.2.3 North America Advanced Therapy Medicinal Products Market Share by Type (2021-2032)
- 7.3 North America Advanced Therapy Medicinal Products Market Size by Application
- 7.3.1 North America Advanced Therapy Medicinal Products Market Size by Application (2021-2026)
- 7.3.2 North America Advanced Therapy Medicinal Products Market Size by Application (2027-2032)
- 7.3.3 North America Advanced Therapy Medicinal Products Market Share by Application (2021-2032)
- 7.4 North America Advanced Therapy Medicinal Products Market Size by Country
- 7.4.1 North America Advanced Therapy Medicinal Products Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 7.4.3 North America Advanced Therapy Medicinal Products Market Size by Country (2027-2032)
- 7.4.4 North America Advanced Therapy Medicinal Products Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Advanced Therapy Medicinal Products Market Size (2021-2032)
- 8.2 Europe Advanced Therapy Medicinal Products Market Size by Type
- 8.2.1 Europe Advanced Therapy Medicinal Products Market Size by Type (2021-2026)
- 8.2.2 Europe Advanced Therapy Medicinal Products Market Size by Type (2027-2032)
- 8.2.3 Europe Advanced Therapy Medicinal Products Market Share by Type (2021-2032)
- 8.3 Europe Advanced Therapy Medicinal Products Market Size by Application
- 8.3.1 Europe Advanced Therapy Medicinal Products Market Size by Application (2021-2026)
- 8.3.2 Europe Advanced Therapy Medicinal Products Market Size by Application (2027-2032)
- 8.3.3 Europe Advanced Therapy Medicinal Products Market Share by Application (2021-2032)
- 8.4 Europe Advanced Therapy Medicinal Products Market Size by Country
- 8.4.1 Europe Advanced Therapy Medicinal Products Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 8.4.3 Europe Advanced Therapy Medicinal Products Market Size by Country (2027-2032)
- 8.4.4 Europe Advanced Therapy Medicinal Products Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Advanced Therapy Medicinal Products Market Size (2021-2032)
- 9.2 China Advanced Therapy Medicinal Products Market Size by Type
- 9.2.1 China Advanced Therapy Medicinal Products Market Size by Type (2021-2026)
- 9.2.2 China Advanced Therapy Medicinal Products Market Size by Type (2027-2032)
- 9.2.3 China Advanced Therapy Medicinal Products Market Share by Type (2021-2032)
- 9.3 China Advanced Therapy Medicinal Products Market Size by Application
- 9.3.1 China Advanced Therapy Medicinal Products Market Size by Application (2021-2026)
- 9.3.2 China Advanced Therapy Medicinal Products Market Size by Application (2027-2032)
- 9.3.3 China Advanced Therapy Medicinal Products Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Advanced Therapy Medicinal Products Market Size (2021-2032)
- 10.2 Asia Advanced Therapy Medicinal Products Market Size by Type
- 10.2.1 Asia Advanced Therapy Medicinal Products Market Size by Type (2021-2026)
- 10.2.2 Asia Advanced Therapy Medicinal Products Market Size by Type (2027-2032)
- 10.2.3 Asia Advanced Therapy Medicinal Products Market Share by Type (2021-2032)
- 10.3 Asia Advanced Therapy Medicinal Products Market Size by Application
- 10.3.1 Asia Advanced Therapy Medicinal Products Market Size by Application (2021-2026)
- 10.3.2 Asia Advanced Therapy Medicinal Products Market Size by Application (2027-2032)
- 10.3.3 Asia Advanced Therapy Medicinal Products Market Share by Application (2021-2032)
- 10.4 Asia Advanced Therapy Medicinal Products Market Size by Country
- 10.4.1 Asia Advanced Therapy Medicinal Products Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 10.4.3 Asia Advanced Therapy Medicinal Products Market Size by Country (2027-2032)
- 10.4.4 Asia Advanced Therapy Medicinal Products Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Type
- 11.2.1 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Application
- 11.3.1 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country
- 11.4.1 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Advanced Therapy Medicinal Products Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst